Home » ACT, Toray Sign Agreement on Innovative Catheter Technology
ACT, Toray Sign Agreement on Innovative Catheter Technology
Advanced Catheter Therapies and Toray Industries have inked a license agreement to manufacture, market and sell Occlusion Perfusion Catheter.
The FDA-cleared OPC is a targeted therapeutic agent delivery system for peripheral vascular stenosis and restenosis.
The OPC is a multi-lumen balloon catheter designed to provide targeted delivery — creating a localized treatment chamber — of various therapeutic and diagnostic agents to the peripheral and coronary vasculature by temporarily occluding a specific region from blood flow. — Joya Patel
Upcoming Events
-
25Apr
-
07May
-
14May
-
30May